Accéder au contenu
Merck

Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori.

Canadian journal of microbiology (2014-01-08)
Eleonora Altman, Blair A Harrison, Vandana Chandan, Robert Slinger
RÉSUMÉ

Lipopolysaccharide (LPS) of Helicobacter pylori exhibits several unique structures, such as Lewis (Le) antigens, α-1,6-glucan, and dd-heptan. To investigate the relationship between LPS structure and resistance to clarithromycin, 41 Canadian isolates of H. pylori were characterized by whole-cell ELISA (enzyme-linked immunosorbent assay), sugar analysis, immunoblotting, and indirect immunofluorescence. The expression of type 2 Lewis X and (or) Lewis Y antigens was detected in 22 of 23 (95.7%) clarithromycin-resistant and in 14 of 18 (77.7%) clarithromycin-susceptible H. pylori strains (P < 0.05), and 8 isolates co-expressed type 1 and type 2 Le antigens (8/41, 19.5%). A significantly higher frequency of α-1,6-glucan (P < 0.01) was detected in clarithromycin-resistant strains than in clarithromycin-susceptible strains (19/23 (82.6%) versus 11/18 (61.1%)). Sugar analysis of selected α-1,6-glucan-positive H. pylori strains confirmed that they frequently contained elevated amounts of dd-heptose. Clarithromycin-resistant isolates were also characterized by low expression levels or absence of CagA (17/23, 73.9%). Indirect immunofluorescence studies carried out on selected H. pylori strains with rabbit immune sera specific for α-1,6-glucan confirmed broad recognition of α-1,6-glucan epitope. The binding was not affected by LPS glycotype of H. pylori isolates examined nor by their CagA status or resistance to clarithromycin. These findings suggest α-1,6-glucan as a potential vaccine target, especially in an era of increasing clarithromycin resistance in H. pylori.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Clarithromycin, ≥95% (HPLC)
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Sigma-Aldrich
Clarithromycin, 96.0-102.0% (HPLC)
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Supelco
Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Le tarif et la disponibilité ne sont pas disponibles actuellement.
Clarithromycin, European Pharmacopoeia (EP) Reference Standard
Le tarif et la disponibilité ne sont pas disponibles actuellement.